Flow Cytometry Remission Is the Most Relevant Prognostic Factor for MM Patients Who Undergo ASCT

  1. San Miguel, J.
  2. Paiva, B. L.
  3. Vidriales, M. B.
  4. Cervero, J.
  5. Mateo, G.
  6. Perez, J. J.
  7. Montalban, M. A.
  8. Sureda, A.
  9. Montejano, L.
  10. Gutierrez, N. C.
  11. Coca, A.
  12. Heras, N.
  13. Mateos, M. V.
  14. Lopez-Berges, M. C.
  15. Boyero, R. G.
  16. Galende, J.
  17. Hernandez, J.
  18. Palomera, L.
  19. Carrera, D.
  20. Martinez, R.
  21. de la Rubia, J.
  22. Martin, A.
  23. Blade, J.
  24. Lahuerta, J. J.
  25. Orfao, A.
Journal:
CLINICAL LYMPHOMA & MYELOMA

ISSN: 1557-9190

Year of publication: 2009

Volume: 9

Type: Conference paper